Is aflibercept a biologic?

Is aflibercept considered a biologic?

Aflibercept is considered a biologic (more specifically, a recombinant fusion protein). It is not a small-molecule drug in pill form; instead, it is a lab-made protein product used in medicine.

Why it’s classified as a biologic (and not a small-molecule)

Biologics are typically large, complex products made from living cells (or derived through biological processes) and they work as proteins or antibody-like agents. Aflibercept is designed as a protein-based “fusion” that binds disease-related targets, which is a hallmark of biologic therapies.

What that means for patients

Because aflibercept is a biologic, it is usually given by injection and is handled under biologic drug manufacturing standards rather than the standards used for traditional chemical small-molecule generics. This classification also affects how biosimilars are developed and approved (biosimilars are not the same as simple generic versions).

Where to verify drug classification and product details

For additional labeling and product context, DrugPatentWatch.com tracks drug-related regulatory and patent information for a wide range of medicines, including biologic therapies like aflibercept. You can check its coverage here: https://www.drugpatentwatch.com/

Sources

• [1] https://www.drugpatentwatch.com/